Abstract:Introduction: SSTR5 is one of five somatostatin receptors that mediate the inhibitory effect of somatostatin (SST) on insulin expression/secretion and islet neoplasia, yet the underlying mechanism remains elusive. Pancreatic and duodenal homeobox-1 (PDX-1) is a β-cell-specific transcription factor essential for pancreatic development and maintenance of β-cell functions. The purpose of this study is to determine whether SST/SSTR5 mechanism of action is regulated via PDX-1. Methods: The effect of SSTR5 agonist PRL-1980 on glucagon-like peptide 1 (GLP-1)-stimulated PDX-1 expression was examined by treating β-TC6 insulinoma cells with 0, 2.5, 5, 10 or 20 nM GLP-1 for 12 h with or without 30-min pretreatment of 100 nM PRL-1980, followed by Western blotting of PDX-1. The effect of p38 inhibitor SB202190 on GLP-1-stimulated PDX-1 expression was examined by treating β-TC6 cells with 20 nM GLP-1 for 12 h in the presence or absence of SB202190, followed by Western blotting of PDX-1. Mouse SSTR5 (mSSTR5) shRNA was generated by annealing and ligating the nucleotide 5'-GCCAAGATGAAGACAGTTA-3' from mSSTR5 cDNA into pSUPER vector at BglII and HindIII sites according to a Dharmacon protocol. The effect of SSTR5 knockdown on PDX-1 in MIN6 insulinoma cells was examined by transfecting mSSTR5 shRNA using Lipofectamine 2000, followed by Western blotting of PDX-1, Cyclin E, Cdk4, p53, p21 and p27 using appropriate antibodies. The effect of SSTR5 on PDX-1 in PANC-1 pancreas cancer cells was examined by co-transfecting HA-SSTR5 with Flag-PDX-1 into the cells using Lipofectamine 2000, followed by Western blotting of Flag-PDX-1. Immunoprecipitation/Western blotting was performed in β-TC6 cells treated with GLP-1 to examine the p38-PDX-1 interaction. The serine 61 and 269 residues of PDX-1 were mutated into alanine by performing site-directed mutagenesis. The effect of p38 on these mutants was examined by co-transfecting them with p38 into HEK-293 cells using Lipofectamine 2000, followed by Western blotting of PDX-1. Islet expression of PDX-1, insulin and PCNA in wild-type and SSTR5-/- mice was measured by immunofluorescent staining using appropriate antibodies. Results: 1. SSTR5 agonist inhibited GLP-1-stimulated increase of PDX-1 expression in β-TC6 cells; 2. GLP-1-stimulated PDX-1 expression was accompanied by kinase activation of p38 MAP kinase and p38-specific inhibitor SB202190 blocked GLP-1-stimulated increase of PDX-1 expression in β-TC6 cells; 3. SSTR5 agonist pretreatment inhibited both p38 kinase activation and PDX-1 expression stimulated by GLP-1; 4. Knockdown of SSTR5 by mSSTR5 shRNA enhanced PDX-1 expression in MIN6 cells, which was accompanied by increased expression of Cyclin E and Cdk4 and decreased expression of p53, p21 and p27; 5. co-transfection of SSTR5 with PDX-1 into PANC-1 cells resulted in down-regulation of PDX-1 in a dose-dependent manner; 6. GLP-1 induced an interaction of p38 with PDX-1 in β-TC6 cells; 7. mutation of serine 269 to alanine abolished the stabilizing effect of p38 on PDX-1 in HEK-293 cells; and 8. ablation of SSTR5 resulted in marked islet overexpression of PDX-1 which was accompanied by increased expression of insulin and PCNA in SSTR5-/- mice. Conclusion: These data suggest that p38 stabilizes PDX-1 through regulating its Ser 269 phosphorylation and that SSTR5 inhibits p38 kinase activation and thus down-regulates PDX-1 expression. We conclude that SST/SSTR5 exert their inhibitory effect via down-regulating PDX-1.

The Tet-On system in transgenic mice: inhibition of the mouse pdx-1 gene activity by antisense RNA expression in pancreatic beta-cells

Reversal of Streptozotocin-Induced Diabetes in Mice by Cellular Transduction with Recombinant Pancreatic Transcription Factor Pancreatic Duodenal Homeobox-1

Forkhead Box O1/Pancreatic and Duodenal Homeobox 1 Intracellular Translocation is Regulated by C-Jun N-Terminal Kinase and Involved in Prostaglandin E-2-Induced Pancreatic Beta-Cell Dysfunction

Expression of pancreatic and duodenal homeobox1 (PDX1) protein in the interior and exterior regions of the intestine, revealed by development and analysis of Pdx1 knockout mice

Conditional Tissue-Specific Foxa2 Ablation in Mouse Pancreas Causes Hyperinsulinemic Hypoglycemia: (RETRACTED)

In Vivo and in Vitro Studies of a Functional Peroxisome Proliferator-activated Receptor Γ Response Element in the Mouse Pdx-1 Promoter

Mutant Pax6 Downregulates Prohormone Convertase 2 Expression in Mouse Islets

Preserving expression of Pdx1 improves β-cell failure in diabetic mice

Characterization of Pancreatic Transcription Factor Pdx-1 Binding Sites Using Promoter Microarray and Serial Analysis of Chromatin Occupancy*

Heterogeneous Development of Β-Cell Populations in Diabetes-Resistant and Susceptible Mice

Defining a Novel Role for the Pdx1 Transcription Factor in Islet β-Cell Maturation and Proliferation During Weaning

Sirt1 Deacetylates Foxa2 And Is Critical For Pdx1 Transcription And Beta-Cell Formation

Reversal of Streptozotocin-Induced Diabetes in Rats by Gene Therapy with Betacellulin and Pancreatic Duodenal Homeobox-1

Negative Regulation of Pancreatic and Duodenal Homeobox-1 by Somatostatin Receptor Subtype 5

Pancreatic and Duodenal Homeobox Gene 1 (pdx1) Down-Regulates Hepatic Transcription Factor 1 Alpha (hnf1α) Expression During Reprogramming of Human Hepatic Cells into Insulin-Producing Cells.

Tectorigenin Enhances PDX1 Expression and Protects Pancreatic Β-Cells by Activating ERK and Reducing ER Stress

Generation and Characterization of Transgenic Mice Expressing Mouse Ins1 Promoter for Pancreatic Β-Cell-specific Gene Overexpression and Knockout.

Phosphorylation-Dependent Stabilization of Pancreatic and Duodenal Homeobox-1 (PDX-1)

Pcif1 modulates Pdx1 protein stability and pancreatic β cell function and survival in mice

SSTR5 Down-Regulates PDX-1 via Inhibition of P38 MAP Kinase

TET1 dioxygenase is required for FOXA2-associated chromatin remodeling in pancreatic beta-cell differentiation